Emnar Pharma Private Limited - Company Profile

It is a pharma private limited company based in Sanath Nagar Hyderabad, Telangana, India, established in 2002.
2002 Sanath Nagar Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Emnar Pharma Private Limited

Emnar Pharma Private Limited, a active private limited company, was established on 23 September 2002 in Sanath Nagar Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24299TG2002PTC039653. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹19.87 Cr.

Formerly known as Emmennar Bio-Tech Private Limited, Emmennar Biotech Private Limited. It upholds a compliant status. Employing 671 professional, Its leadership includes Vamshidhar Reddy Kallem (Director), Venkatarami Reddy (Director), Sudha Mundla (Director). Past directors included Narayana Reddy Mundla, Vamshidhar Reddy Kallem, Venkatarami Reddy. It holds ₹70.30 Cr open charges and ₹36.91 Cr settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2024. It is based at Plot No: A - 4, Mch No: 7 - 2 - A4, Industrial Estate, Opp:Sanath Nagar Police Station,, Sanath Nagar Hyderabad, Telangana, 500018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299TG2002PTC039653

  • Registration Number

    039653

  • Incorporation Date

    23 September 2002

  • Authorized Capital

    ₹20.00 Cr

  • Paid-Up Capital

    ₹19.87 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 20.00 Cr
  • Paid Up Capital ₹ 19.87 Cr
  • Company Age 23 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 70.30 Cr
  • Satisfied Charges ₹ 36.91 Cr
  • Revenue Growth **** 13.11%
  • Profit Growth **** -6.78%
  • Ebitda **** -3.04%
  • Net Worth 8.50%
  • Total Assets **** 3.47%
Company report

Emnar Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Emnar Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Emnar Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Vamshidhar Reddy Kallem Director 18 Nov 2013 Current
Venkatarami Reddy Director 01 Aug 2015 Current
Sudha Mundla Director 23 Sep 2002 Current
Mundla Maha Vishnu Director 01 Aug 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Oct 2013 Past
Pramod Abcsdd Additional Director 28 Jul 2014 Past
Pramod Abcsdd Additional Director 23 Sep 2015 Past
Pramod Abcsdd Director 02 Jun 2020 Past
Pramod Abcsdd Additional Director 16 Sep 2011 Past
Pramod Abcsdd Director 28 Feb 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Emnar Pharma.

Emnar Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.11% increase. The company also saw a slight decrease in profitability, with a 6.78% decrease in profit. The company's net worth moved up by a moderate rise of 8.5%.

Emnar Pharma revenue growth over time
Emnar Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 13.11%
*******
*******
*******
*******
Revenue from Operations
*******
 13.35%
*******
*******
*******
*******
Total Assets
*******
 3.47%
*******
*******
*******
*******
Profit or Loss
*******
 -6.78%
*******
*******
*******
*******
Net Worth
*******
 8.50%
*******
*******
*******
*******
EBITDA
*******
 -3.04%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Emnar Pharma?

In 2023, Emnar Pharma had a promoter holding of 100.00%. The company had 3 Joint Ventures. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹703,000,000.00

Satisfied Charges

₹369,145,000.00

Charges Breakdown by Lending Institutions
  • Citi Bank N.A. : 60.00 Cr
  • State Bank Of India : 10.30 Cr
Latest Charge Details
Date Lender Amount Status
04 May 2015 Citi Bank N.A. ₹60.00 Cr Open
30 Aug 2010 State Bank Of India ₹10.30 Cr Open
04 May 2015 Citi Bank N.A. ₹30.00 Cr Satisfied
01 Feb 2011 Canara Bank ₹0.80 M Satisfied
26 Jul 2010 Canara Bank ₹0.64 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Emnar Pharma?

Emnar Pharma has a workforce of 671 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Emnar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emnar Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Emnar Pharma
Recent Activity within the Organization
  • Charges

    Progress on A charge with Citi Bank N.A. of Rs. 60.00 Cr registered on 04 May 2015 with Charge ID 10577307 was modified on 03 Dec 2025. was documented.

  • Annual General Meeting

    Progress on Emnar Pharma Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Emnar Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.

  • Charges

    A charge with State Bank Of India of Rs. 10.30 Cr registered on 30 Aug 2010 with Charge ID 10241377 was modified on 25 Jun 2021. was recorded as a recent event.

  • Charges

    The activity A charge registered on 04 May 2015 via Charge ID 10577214 with Citi Bank N.A. was fully satisfied on 04 Aug 2020. was completed.

  • Director Appointment

    Progress on Monika Sharma was appointed as a Company Secretary was appointed as a Company Secretary on 24 Jul 2017 & has been associated with this company since 8 years 6 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Emnar Pharma Private Limited?

The CIN of Emnar Pharma Private Limited is U24299TG2002PTC039653.

Where is Emnar Pharma Private Limited headquartered?

Emnar Pharma Private Limited is headquartered at Plot No: A - 4, Mch No: 7 - 2 - A4, Industrial Estate, Opp:Sanath Nagar Police Station,, Sanath Nagar Hyderabad, Telangana, 500018.

When was Emnar Pharma Private Limited incorporated?

Emnar Pharma Private Limited was incorporated on 23 September 2002.

Who are the current directors of Emnar Pharma Private Limited?

The current directors of Emnar Pharma Private Limited are

What is the primary industry of Emnar Pharma Private Limited?

The primary industry of Emnar Pharma Private Limited is Manufacturing.

Is Emnar Pharma Private Limited a listed company?

Emnar Pharma Private Limited is unlisted.

What is the capital structure of Emnar Pharma Private Limited?

The authorized capital of Emnar Pharma Private Limited is ₹20.00 Cr, and the paid-up capital is ₹19.87 Cr.

What is the compliance status of Emnar Pharma Private Limited?

The compliance status of Emnar Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available